Your Health, We Care
Strong CYP3A inhibitors: Concomitant use should be avoided; if coadministration is unavoidable, the dose of ponatinib should be reduced.
Strong CYP3A inducers: Concomitant use should be avoided.
FDA,2022.02
At present, the core objective of research related to ponatinib is to improve its medication safety ···【more】
Recommended：222026-21-01
Patients should maintain a written list of all prescription drugs, over-the-counter (OTC) medication···【more】
Recommended：242026-21-01
At present, the core objective of research related to ponatinib is to improve its medication safety and therapeutic efficacy.Which drugs interact with Ponatinib?Combination use of ···【more】
Article source：Lucius LaosRelease date：2026-01-21Recommended：22
Patients should maintain a written list of all prescription drugs, over-the-counter (OTC) medications, vitamins, minerals, and dietary supplements they are taking. This list must b···【more】
Article source：Lucius LaosRelease date：2026-01-21Recommended：24
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
